See also this year's filing and all EDGAR filings for this company.
PDF Report 0000822370_2021_Emmaus_Life_Sciences_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0000822370, Emmaus Life Sciences Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 11,257,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 120,000 |
| 3 | remainder_Assets | 47,898,000 |
| 4 | LiabilitiesCurrent | 23,382,000 |
| 5 | LiabilitiesNoncurrent | 37,940,000 |
| 6 | remainder_Liabilities | 3,372,000 |
| 7 | CostOfGoodsAndServicesSold | 1,489,567 |
| 8 | SellingGeneralAndAdministrativeExpense | 16,378,005 |
| 9 | ResearchAndDevelopmentExpense | 2,408,000 |
| 10 | remainder_Expenses | 4,712,844 |
| 11 | remainder_Revenues | 23,167,000 |
| 12 | remainder_NetIncome | 615,601 |
| 13 | remainder_ComprehensiveNetIncome | 1,216,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 59,275,000 |
| 1 | Liabilities | 64,694,000 |
| 2 | Expenses | 24,988,416 |
| 3 | Revenues | 23,167,000 |
| 4 | StockholdersEquity | -5,419,000 |
| 5 | NetIncome | -1,205,815 |
| 6 | ComprehensiveNetIncome | -597,815 |
| 7 | BaseVar | 86,978,008 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.200 |
| 9 | EconomicCapitalRatio | 1.41 |
Edgar->Model Mapping
Feature Distribution
Change over Time
